BTTX
Income statement / Annual
Last year (2022), Better Therapeutics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, Better Therapeutics, Inc.'s net income was -$39.76 M.
See Better Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$8,000.00
|
$18,000.00
|
| Cost of Revenue |
$2.73 M |
$1.62 M |
$682,000.00 |
$898,000.00 |
| Gross Profit |
-$2.73 M |
-$1.62 M |
-$674,000.00 |
-$880,000.00 |
| Gross Profit Ratio |
0 |
0 |
-84.25 |
-48.89 |
| Research and Development
Expenses |
$16.44 M
|
$19.44 M
|
$2.98 M
|
$2.29 M
|
| General & Administrative
Expenses |
$14.84 M
|
$8.79 M
|
$2.46 M
|
$2.20 M
|
| Selling & Marketing
Expenses |
$6.98 M
|
$2.34 M
|
$216,000.00
|
$406,000.00
|
| Selling, General &
Administrative Expenses |
$21.82 M
|
$11.12 M
|
$2.67 M
|
$2.60 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$38.26 M |
$30.56 M |
$5.65 M |
$4.89 M |
| Cost And Expenses |
$38.26 M |
$30.56 M |
$6.33 M |
$5.79 M |
| Interest Income |
$1,491.00 |
$185.00 |
$100.00 |
$11.00 |
| Interest Expense |
$1.49 M |
$185,000.00 |
$100,000.00 |
$11,000.00 |
| Depreciation &
Amortization |
$2.73 M
|
$1.62 M
|
$75,000.00
|
$72,000.00
|
| EBITDA |
-$38.26 M
|
-$30.56 M
|
-$6.25 M
|
-$5.70 M
|
| EBITDA Ratio |
0 |
0 |
-781 |
-316.72 |
| Operating Income Ratio
|
0
|
0
|
-790.38
|
-320.72
|
| Total Other
Income/Expenses Net |
-$1.49 M
|
-$9.93 M
|
$89,000.00
|
-$11,000.00
|
| Income Before Tax |
-$39.75 M |
-$40.49 M |
-$6.23 M |
-$5.78 M |
| Income Before Tax Ratio
|
0
|
0
|
-779.25
|
-321.33
|
| Income Tax Expense |
$7,000.00 |
-$153,000.00 |
$153,000.00 |
$11,000.00 |
| Net Income |
-$39.76 M |
-$40.34 M |
-$6.39 M |
-$5.80 M |
| Net Income Ratio |
0 |
0 |
-798.38 |
-321.94 |
| EPS |
-1.69 |
-1.71 |
-0.85 |
-0.25 |
| EPS Diluted |
-1.69 |
-1.71 |
-0.85 |
-0.25 |
| Weighted Average Shares
Out |
$23.56 M
|
$23.60 M
|
$7.56 M
|
$23.60 M
|
| Weighted Average Shares
Out Diluted |
$23.56 M
|
$23.60 M
|
$7.56 M
|
$23.60 M
|
| Link |
|
|
|
|
